AGL 24.24 Increased By ▲ 0.77 (3.28%)
AIRLINK 107.70 Increased By ▲ 1.59 (1.5%)
BOP 5.12 Decreased By ▼ -0.05 (-0.97%)
CNERGY 3.63 Decreased By ▼ -0.03 (-0.82%)
DCL 7.32 Decreased By ▼ -0.48 (-6.15%)
DFML 42.10 Decreased By ▼ -2.09 (-4.73%)
DGKC 88.80 Increased By ▲ 0.30 (0.34%)
FCCL 21.75 No Change ▼ 0.00 (0%)
FFBL 41.85 Decreased By ▼ -0.67 (-1.58%)
FFL 8.61 Decreased By ▼ -0.14 (-1.6%)
HUBC 148.75 Increased By ▲ 0.95 (0.64%)
HUMNL 10.14 Decreased By ▼ -0.11 (-1.07%)
KEL 4.28 Decreased By ▼ -0.06 (-1.38%)
KOSM 3.59 Decreased By ▼ -0.20 (-5.28%)
MLCF 36.20 Decreased By ▼ -0.20 (-0.55%)
NBP 47.75 Decreased By ▼ -1.55 (-3.14%)
OGDC 129.10 Decreased By ▼ -1.75 (-1.34%)
PAEL 25.75 Decreased By ▼ -0.20 (-0.77%)
PIBTL 6.00 Decreased By ▼ -0.05 (-0.83%)
PPL 113.65 Decreased By ▼ -0.90 (-0.79%)
PRL 22.30 Decreased By ▼ -0.30 (-1.33%)
PTC 12.10 Decreased By ▼ -0.27 (-2.18%)
SEARL 54.98 Decreased By ▼ -0.72 (-1.29%)
TELE 7.11 Decreased By ▼ -0.14 (-1.93%)
TOMCL 37.11 Increased By ▲ 0.71 (1.95%)
TPLP 7.76 Decreased By ▼ -0.19 (-2.39%)
TREET 15.00 Decreased By ▼ -0.29 (-1.9%)
TRG 55.54 Decreased By ▼ -1.16 (-2.05%)
UNITY 31.20 Decreased By ▼ -0.65 (-2.04%)
WTL 1.15 Decreased By ▼ -0.02 (-1.71%)
BR100 8,248 Decreased By -46.7 (-0.56%)
BR30 25,878 Decreased By -223.8 (-0.86%)
KSE100 78,030 Decreased By -439.8 (-0.56%)
KSE30 25,084 Decreased By -114.2 (-0.45%)
World

Germany's COVID-19 vaccination centres to hit capacity by end of March

  • Germany has so far been starved of shots as drugmakers faced production problems, but shortages are likely to ease as deliveries accelerate.
  • BioNTech's shot, made in partnership with US drug company Pfizer, was the first to win approval for use in the European Union.
Published February 10, 2021

BERLIN: Germany will run up against limits on its capacity to inoculate people against COVID-19 by the end of March, health ministry documents showed, as an expected increase in supply puts its network of vaccination centres to the test.

Germany has so far been starved of shots as drugmakers faced production problems, but shortages are likely to ease as deliveries accelerate, according to a revised vaccine strategy released by the health ministry on Wednesday.

The strategy update came as German biotech startup BioNTech launched a new facility in the German town of Marburg, expecting first vaccines made there to be distributed in early April.

BioNTech's shot, made in partnership with US drug company Pfizer, was the first to win approval for use in the European Union.

Germany is also getting vaccines from Moderna and AstraZeneca. The Pfizer and Moderna shots need to be kept frozen, while Astra's can be stored in a fridge, making it suitable for administration by family doctors.

Around 2.4 million people have been vaccinated in Germany, or 2.9% of the population, since it started vaccinations in December, health ministry data showed.

Initial shortages should give way in the second quarter to more abundant supply, when Germany expects to receive 77 million vaccine doses. Chancellor Angela Merkel has promised shots to all adults who want one by the end of the summer.

To reach this target, vaccinations will be offered at general practitioners' clinics, working in parallel with the existing network of more than 400 vaccination centres, the plan document read.

"It is becoming clear that the vaccination centres will have to continue to operate for a longer period of time, even after doctors' practices are involved," it read.

In the plan, Germany's Institute for Statutory Health Care (Zi) recommended increasing the daily capacity of vaccination centres to 300,000 from 200,000 to meet targets.

According to Zi calculations and based on drugmakers' delivery commitments, Germany will be able to inoculate around three million people a week from May and administer around one million shots a day by the end of June.

Comments

Comments are closed.